国产宫颈癌疫苗落地,关于它你不知道的都在这里

2021-03-29 39健康网 39健康网

3月26日,国产宫颈癌二价疫苗在北京启动第一针接种。宫颈癌疫苗,是女性远离宫颈癌有效的工具。

3月26日,国产宫颈癌二价疫苗在北京启动第一针接种。宫颈癌早期几乎没有临床症状,即使到医院检查,肉眼也难以辨别早期病变,要发现宫颈癌必须通过筛查,包括细胞学和HPV检测两种方法。宫颈癌疫苗是女性远离宫颈癌有效的工具。

一、什么样的行为会导致HPV感染?

1、发生性行为时间早。

研究统计表型,首次性行为年龄越小者,在其生命后期发生HPV感染的危险性越高,尤其是首次X交发生在15岁前的女性。

2、有多个性伴侣或性较频繁。

HPV可以通过X交进行传播,若同时存在多个性伴侣和频繁X交的行为,就会增大因为X交而感染HPV的风险。

3、吸烟。

吸烟第一能够降低我们身体的免疫能力,在感染HOV时无法通过自身免疫系统进行自愈;第二是烟草中本身含有超过60种的致癌物质成分,会引起身体多组织部位的癌症,其中也包括宫颈癌。

二、有必要接种hpv疫苗吗?

宫颈癌是女性常见的妇科恶性肿瘤疾病。导致女性得宫颈癌的原因有多种,但人乳头瘤病毒(HPV)持续感染是宫颈癌的主要致病因素,90%以上的宫颈癌女性都伴有高危型HPV感染。因此只要能够预防高危型HPV病毒感染,就可以降低90%的宫颈癌得病几率。

三、2价、4价、9价有什么区别?

HPV 2价疫苗

公开资料显示,2价疫苗可预防感染率高的HPV16、18型。80%的肝门癌、70%的宫颈癌、60%的引导肿瘤、40%的外阴癌均由着两类病毒导致。国内推荐适宜接种年龄为9—45岁女性。

HPV 4价疫苗

4价疫苗可用于预防由HPV 6、11、16、18型病毒导致的疾病。国内推荐适宜接种年龄为20—45岁女性。

HPV 9价疫苗

9价疫苗针对HPV的九种亚型,基本包含目前已知的所有人乳头瘤病毒治病种类,可以防治HPV 6、11、16、18、31、33、45、52和58型九种病毒。国内推荐适宜接种年龄为16—26岁女性。

三种宫颈癌疫苗只要接种其中第一种并完成全部的注射剂次后,便可预防70%以上的HPV感染,无需再接受另第一种的宫颈癌疫苗注射。尽早接种HPV疫苗,消除宫颈癌势在必行。

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1408279, encodeId=37f114082e976, content=<a href='/topic/show?id=92194628826' target=_blank style='color:#2F92EE;'>#宫颈#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=46288, encryptionId=92194628826, topicName=宫颈)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=11102737131, createdName=一闲, createdTime=Wed Mar 31 07:10:37 CST 2021, time=2021-03-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1663778, encodeId=72e91663e7896, content=<a href='/topic/show?id=6a124631390' target=_blank style='color:#2F92EE;'>#宫颈癌疫苗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=46313, encryptionId=6a124631390, topicName=宫颈癌疫苗)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=077725685033, createdName=12498adam48暂无昵称, createdTime=Thu Jul 29 16:10:37 CST 2021, time=2021-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=952112, encodeId=a5a79521121b, content=好文章!, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Mon Mar 29 17:18:33 CST 2021, time=2021-03-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=952092, encodeId=a029952092a6, content=。国内推荐适宜接种年龄为20—45岁女性。, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/02/7354b3539aae6a0ccb1e0fff04c12084.jpg, createdBy=205b1984786, createdName=随梦飞扬, createdTime=Mon Mar 29 16:50:54 CST 2021, time=2021-03-29, status=1, ipAttribution=)]
    2021-03-31 一闲
  2. [GetPortalCommentsPageByObjectIdResponse(id=1408279, encodeId=37f114082e976, content=<a href='/topic/show?id=92194628826' target=_blank style='color:#2F92EE;'>#宫颈#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=46288, encryptionId=92194628826, topicName=宫颈)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=11102737131, createdName=一闲, createdTime=Wed Mar 31 07:10:37 CST 2021, time=2021-03-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1663778, encodeId=72e91663e7896, content=<a href='/topic/show?id=6a124631390' target=_blank style='color:#2F92EE;'>#宫颈癌疫苗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=46313, encryptionId=6a124631390, topicName=宫颈癌疫苗)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=077725685033, createdName=12498adam48暂无昵称, createdTime=Thu Jul 29 16:10:37 CST 2021, time=2021-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=952112, encodeId=a5a79521121b, content=好文章!, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Mon Mar 29 17:18:33 CST 2021, time=2021-03-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=952092, encodeId=a029952092a6, content=。国内推荐适宜接种年龄为20—45岁女性。, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/02/7354b3539aae6a0ccb1e0fff04c12084.jpg, createdBy=205b1984786, createdName=随梦飞扬, createdTime=Mon Mar 29 16:50:54 CST 2021, time=2021-03-29, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1408279, encodeId=37f114082e976, content=<a href='/topic/show?id=92194628826' target=_blank style='color:#2F92EE;'>#宫颈#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=46288, encryptionId=92194628826, topicName=宫颈)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=11102737131, createdName=一闲, createdTime=Wed Mar 31 07:10:37 CST 2021, time=2021-03-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1663778, encodeId=72e91663e7896, content=<a href='/topic/show?id=6a124631390' target=_blank style='color:#2F92EE;'>#宫颈癌疫苗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=46313, encryptionId=6a124631390, topicName=宫颈癌疫苗)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=077725685033, createdName=12498adam48暂无昵称, createdTime=Thu Jul 29 16:10:37 CST 2021, time=2021-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=952112, encodeId=a5a79521121b, content=好文章!, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Mon Mar 29 17:18:33 CST 2021, time=2021-03-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=952092, encodeId=a029952092a6, content=。国内推荐适宜接种年龄为20—45岁女性。, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/02/7354b3539aae6a0ccb1e0fff04c12084.jpg, createdBy=205b1984786, createdName=随梦飞扬, createdTime=Mon Mar 29 16:50:54 CST 2021, time=2021-03-29, status=1, ipAttribution=)]
    2021-03-29 jyzxjiangqin

    好文章!

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1408279, encodeId=37f114082e976, content=<a href='/topic/show?id=92194628826' target=_blank style='color:#2F92EE;'>#宫颈#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=46288, encryptionId=92194628826, topicName=宫颈)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=11102737131, createdName=一闲, createdTime=Wed Mar 31 07:10:37 CST 2021, time=2021-03-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1663778, encodeId=72e91663e7896, content=<a href='/topic/show?id=6a124631390' target=_blank style='color:#2F92EE;'>#宫颈癌疫苗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=46313, encryptionId=6a124631390, topicName=宫颈癌疫苗)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=077725685033, createdName=12498adam48暂无昵称, createdTime=Thu Jul 29 16:10:37 CST 2021, time=2021-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=952112, encodeId=a5a79521121b, content=好文章!, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Mon Mar 29 17:18:33 CST 2021, time=2021-03-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=952092, encodeId=a029952092a6, content=。国内推荐适宜接种年龄为20—45岁女性。, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/02/7354b3539aae6a0ccb1e0fff04c12084.jpg, createdBy=205b1984786, createdName=随梦飞扬, createdTime=Mon Mar 29 16:50:54 CST 2021, time=2021-03-29, status=1, ipAttribution=)]
    2021-03-29 随梦飞扬

    。国内推荐适宜接种年龄为20—45岁女性。

    0

相关资讯

这四种癌症,早期发现或能控制!

有很多癌症类型若能在早期发现、积极控制,患者病情都能得到良好的治疗,甚至是可以达到临床治愈的标准,特别是以下四种癌症。

关注“她健康”,全国政协委员呼吁宫颈癌防控关口逐步前移

3月4日是第四届国际HPV知晓日,多位全国政协委员呼吁,宫颈癌的防控关口应逐步前移,提升HPV疫苗接种率。

Libtayo提高了宫颈癌患者的生存率!

赛诺菲和Regeneron的PD-1抑制剂Libtayo在晚期宫颈癌的III期临床试验中显示出阳性的总体生存(OS)结果。

Br J Cancer:LIMCH1和HLA-DQB1为侵袭性宫颈癌的潜在标志物

宫颈癌是全球女性中的第四大癌症类型,且造成每年超过311,000名患者致命。大多数的癌症相关死亡与该疾病一级治疗后出现的肿瘤转移或疾病的复发相关。

Inovio宣布DNA免疫疗法治疗宫颈癌变创新药III期临床成功

Inovio宣布了一项针对宫颈癌前病变的VGX-3100首个III期临床试验的积极结果,在此项多中心、随机、双盲、安慰剂对照临床 III 期试验中,针对全部可评估受试者达到临床疗效的主要终点和所有次要